Antipsychotic potential of RO 20 1724, a PDE4 inhibitor

被引：0
|
作者：
Halene, T. B. [1 ]
Siegel, S. J. [1 ]
机构：
[1] Univ Penn, Philadelphia, PA 19104 USA
来源：
BEHAVIOURAL PHARMACOLOGY | 2007年 / 18卷
关键词：
D O I：
暂无
中图分类号：
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号：
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要：
引用
收藏
页码：S12 / S12
页数：1
相关论文
共 50 条
  • [21] Apremilast: a PDE4 inhibitor for the treatment of psoriatic arthritis
    Abdulrahim, Hunar
    Thistleton, Samuel
    Adebajo, Adewale O.
    Shaw, Tim
    Edwards, Christopher
    Wells, Alvin
    EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (07) : 1099 - 1108
  • [22] Chlorbipram: A novel PDE4 inhibitor with improved safety as a potential antidepressant and cognitive enhancer
    Zhang, Ming-Zi
    Zhou, Zhong-Zhen
    Yuan, Xin
    Cheng, Yu-Fang
    Bi, Bing-Tian
    Gong, Mei-Fang
    Chen, Yu-Pin
    Xu, Jiang-Ping
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2013, 721 (1-3) : 56 - 63
  • [23] Highly potent PDE4 inhibitors with therapeutic potential
    Ochiai, H
    Ohtani, T
    Ishida, A
    Kusumi, K
    Kato, M
    Kohno, H
    Kishikawa, K
    Obata, T
    Nakai, H
    Toda, M
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (01) : 207 - 210
  • [24] Pharmacokinetic characteristics of the selective phosphodiesterase 4 (PDE4)-inhibitor roflumilast
    Bethke, T. D.
    Lahu, G.
    Moll-Schueler, I.
    Gleiter, C. H.
    WIENER KLINISCHE WOCHENSCHRIFT, 2010, 122 (21-22) : A59 - A59
  • [25] A Practical Synthesis of the PDE4 Inhibitor, KW-4490
    Yanagisawa, Arata
    Nishimura, Koichiro
    Ando, Kyoji
    Nezu, Tetsuya
    Maki, Ayako
    Kato, Sachiko
    Tamaki, Wakako
    Imai, Eiichiro
    Mohri, Shin-ichiro
    ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2010, 14 (05) : 1182 - 1187
  • [26] Pharmacokinetic characteristics of the selective phosphodiesterase 4 (PDE4)-inhibitor roflumilast
    Bethke, T. D.
    Lahu, G.
    Gooss, A.
    Gleiter, C. H.
    SWISS MEDICAL WEEKLY, 2010, 140 (13-14) : 13S - 14S
  • [27] Rolipram, a PDE4 inhibitor, shows efficacy in animal models of antipsychotic-like activity: Studies using PDE4b and PDE4D knockout mice
    Chapin, D. S.
    McCarthy, S. A.
    Martin, A. N.
    Siuciak, J. A.
    SCHIZOPHRENIA BULLETIN, 2007, 33 (02) : 470 - 470
  • [28] Pharmacological activity of difamilast, a novel PDE4 inhibitor for the topical treatment of atopic dermatitis: Comparison with other PDE4 inhibitors
    Hiyama, Hidetaka
    Arichika, Naoya
    Sakurai, Kazushi
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB255 - AB255
  • [29] Assessing the emetic potential of PDE4 inhibitors in rats
    Robichaud, A
    Savoie, C
    Stamatiou, PB
    Lachance, N
    Jolicoeur, P
    Rasori, R
    Chan, CC
    BRITISH JOURNAL OF PHARMACOLOGY, 2002, 135 (01) : 113 - 118
  • [30] PDE4 inhibitors
    Lloyd, AW
    DRUG DISCOVERY TODAY, 2000, 5 (12) : 571 - 571
12345